IA
ZVRA icon

IFG Advisors’s Zevra Therapeutics ZVRA Stock Holding History

IFG Advisors’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$576K Buy
61,842
+32,792
+113% +$296K 0.09% 86
2025
Q4 		$260K Hold
29,050
– – 0.04% 131
2025
Q3 		$276K Hold
29,050
– – 0.05% 127
2025
Q2 		$256K Hold
29,050
– – 0.04% 138
2025
Q1 		$218K Hold
29,050
– – 0.04% 140
2024
Q4 		$242K Buy
29,050
+2,650
+10% +$22.6K 0.05% 127
2024
Q3 		$183K Buy
26,400
+7,700
+41% +$52.3K 0.04% 139
2024
Q2 		$91.6K Hold
18,700
– – 0.02% 135
2024
Q1 		$108K Buy
18,700
+5,800
+45% +$35.7K 0.03% 127
2023
Q4 		$84.5K Hold
12,900
– – 0.02% 124
2023
Q3 		$62.2K Sell
12,900
-1,150
-8% -$5.74K 0.02% 116
2023
Q2 		$71.7K Buy
+14,050
New +$75.7K 0.03% 117

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return